Ulifosep 100000Iu Inj
₹1620*
MRP ₹1800
10% off
₹1530*
MRP ₹1800
15% CB
₹270 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Ulifosep 100000Iu Inj belongs to the class of medicine called protease inhibitors. It is used in the treatment of severe sepsis (a condition triggered by an extreme response of the immune system to infections) and acute pancreatitis (inflammation of the pancreas).
Ulifosep 100000Iu Inj contains Ulinastatin as an active ingredient, which belongs to the protease inhibitor class of drugs. It works by inhibiting serine proteases, including trypsin, chymotrypsin, kallikrein, plasmin, thrombin, factors IXa, Xa, XIa, and XlIa. This helps prevent organ dysfunction.
Ulifosep 100000Iu Inj may cause certain side effects, such as nausea, vomiting, headache, skin rash, itching, diarrhoea, allergic reactions and pain at the site of injection. These side effects do not require medical attention and gradually resolve over time. A trained healthcare professional will administer it. Do not self-administer.
Ulifosep 100000Iu Inj should be avoided if you are allergic to it or any other components present in it. Before administration, inform your doctor if you have liver/kidney disease, cardiac disorders, bleeding disorders or respiratory conditions. It is unknown whether Ulifosep 100000Iu Inj is suitable for use in pregnant and breastfeeding mothers. Hence, inform your doctor if you are pregnant, are planning to become pregnant or are breastfeeding beforehand.
Ulifosep 100000Iu Inj contains Ulinastatin as an active ingredient used in the treatment of sepsis and pancreatitis. It belongs to the protease inhibitor class of drugs that works by activating and inhibiting serine proteases, including trypsin, chymotrypsin, kallikrein, plasmin, granulocyte elastase, cathepsin, thrombin, and factors IXa, Xa, XIa, and XlIa. This reduces the pro-inflammatory response due to disease and helps prevent organ dysfunction.
Ulifosep 100000Iu Inj should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before administration, inform your doctor if you have liver/kidney disease, cardiac disorders, bleeding disorders or respiratory conditions. Ulifosep 100000Iu Inj should be avoided in children as safety and efficacy are not established. It is unknown whether Ulifosep 100000Iu Inj is suitable for use in pregnant and breastfeeding mothers. Hence, inform your doctor if you are pregnant, are planning to become pregnant or are breastfeeding beforehand.
Drug-Drug Interactions: No interactions found.
Drug-Food Interactions: No interactions found.
Drug-Disease Interactions: Inform your doctor if you have kidney or liver disease, blood disorders, and pulmonary disorders before receiving Ulifosep 100000Iu Inj.
Sepsis: It is a life-threatening illness caused by the body's response to an infection. Sepsis occurs when chemicals released in the blood to fight infection trigger inflammation in the body. This may lead to a cascade of changes that damage multiple organ systems, leading them to fail, sometimes even resulting in death. Symptoms may include low blood pressure, chills, dizziness, fatigue, fever, flushing, low body temperature, shivering, fast breathing, shortness of breath, etc.
Pancreatitis: Pancreas play an important role in the digestion of food. It produces enzymes which help in the breakdown of food and absorption of nutrients. Swelling of the pancreas is referred to as pancreatitis. It may be of sudden onset, or it may develop as a chronic condition. Symptoms may include nausea, vomiting and abdominal pain. Alcoholics are more prone to this condition.
Country of origin
Manufacturer/Marketer address
Alcohol
Unsafe
Avoid alcohol consumption during the treatment as it can increase the adverse effects and worsen the condition.
Pregnancy
Caution
Limited data is available on the effect of Ulifosep 100000Iu Inj in pregnancy. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Ulifosep 100000Iu Inj. Your doctor may prescribe this medicine if the benefits outweigh the risks.
Breast Feeding
Caution
Limited data is available on the effect of Ulifosep 100000Iu Inj on breastfeeding. Hence, if you are a nursing mother, inform your doctor before receiving Ulifosep 100000Iu Inj. You should not breastfeed while on treatment with Ulifosep 100000Iu Inj.
Driving
Not applicable
Ulifosep 100000Iu Inj will be administered in the hospital setting. Hence, avoid driving.
Liver
Consult your doctor
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Ulifosep 100000Iu Inj. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Kidney
Consult your doctor
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Ulifosep 100000Iu Inj. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition.
Children
Unsafe
Ulifosep 100000Iu Inj is not recommended for use in children as the safety and efficacy are not established.
Product Substitutes
We provide you with authentic, trustworthy and relevant information